Catalyst
Slingshot members are tracking this event:
BioDelivery Sciences Announces the Securing of Preferred Formulary Status for BUNAVAIL on a Significant Managed Care Plan
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
BDSI |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 11, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Bunavail, Formulary Status, Buprenorphine, Naloxone, Opioid Dependence